C. Ahonen

发表

Regulation of G1 cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.

J. Albrecht, B. Rieland, C. Nelsen, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Regulation of G 1 cyclin-dependent kinases in the liver : role of nuclear localization and p 27 sequestration

J. Albrecht, B. Rieland, C. Nelsen, 1999 .

Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN

C. Ahonen, R. Noelle, W. Wade, 2004, The Journal of experimental medicine.

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod.

R. Miller, C. Ahonen, Richard L. Miller, 1999, Cellular immunology.

Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848.

C. Ahonen, R. M. Smith, M. Tomai, 1999, Cellular immunology.

BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells

R. Bram, W. Cook, C. Ahonen, 2004, The Journal of experimental medicine.

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

David C. Gondek, A. Fiser, S. Almo, 2011, The Journal of experimental medicine.

neointima formation and arterial remodeling The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in

L. Beckers, M. Daemen, A. Zernecke, 2013 .

The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells

C. Ahonen, L. Erickson, R. Noelle, 2002, Nature Immunology.

The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.

W. Cook, C. Ahonen, Ling-Li Lin, 2007, Blood.

The in vivo function of a non-canonical TRAF 2 binding domain in the C-terminus of CD 40 in driving B cell growth and differentiation

W. Cook, C. Ahonen, Ling-Li Lin, 2007 .

Cross-Presentation of Soluble Antigens B 2 Pathway κ Dendritic Cells Require the NF -

B. Becher, C. Ahonen, R. Noelle, 2008 .

Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens1

Burkhard Becher, Evan F. Lind, B. Becher, 2008, The Journal of Immunology.

CD40-Associated TRAF 6 Signaling Is Required for Disease Induction in a Retrovirus-Induced Murine Immunodeficiency

W. Cook, C. Ahonen, W. Green, 2004, Journal of Virology.

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver

J. Albrecht, B. Rieland, C. Ahonen, 1998, Oncogene.

Tryptophan hydroxylase-1 regulates immune tolerance and inflammation

C. Ahonen, R. Noelle, A. Wasiuk, 2012, The Journal of experimental medicine.

Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery.

M. Atkins, T. Crocenzi, J. Fisher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

Oliver Soehnlein, Christian Weber, Anna M. Keller, 2010, The Journal of experimental medicine.

The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling.

L. Beckers, M. Daemen, A. Zernecke, 2008, Blood.

Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.

M. Ernstoff, C. Ahonen, R. Noelle, 2008, Blood.

In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.

C. Ahonen, A. Gewirtz, J. Cubillos-Ruiz, 2009, Cancer research.

Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity